Brian Morris (biologist)

Last updated

Brian J. Morris
Born (1950-07-14) 14 July 1950 (age 73)
Adelaide, Australia
NationalityAustralian
Alma mater University of Adelaide, Monash University, University of Melbourne
Known forWork on the renin-angiotensin system, hypertension, circumcision
Awards Royal Society of New South Wales' Edgeworth David Medal (1985)
Scientific career
Fields Molecular biology, molecular genetics
Institutions University of Sydney
Thesis The renin-angiotensin system in kidney cells (1975)

Brian James Morris (born 14 July 1950) [1] is a professor emeritus of molecular medical sciences at the University of Sydney, Australia.

Contents

Education and appointments

Brian Morris grew up in Adelaide, South Australia, where he graduated from the University of Adelaide in 1972. He then completed his PhD at Monash University and the University of Melbourne in 1975. From 1975–1978 he did postdoctoral research at the University of Missouri, and the University of California, San Francisco, first as a CJ Martin fellow, and then as an Advanced Fellow of the American Heart Association. He was then appointed as an academic at the University of Sydney in 1978, was appointed a professor in 1999, and was appointed Professor Emeritus in 2013. [2] [3] He retired in 2014 and the Bosch Institute of Medical Research took over his lab space. [4] :18

Career

Morris studied the Renin–angiotensin system (RAS) for most of his career. His interest in RAS began during his undergraduate studies, when he worked for a while in the laboratory where Eugenie Lumbers had just found early clues to the existence of prorenin (the protein precursor of renin) during her PhD work. He remained interested in the field, and had the good fortune to move to the University of California, San Francisco in the mid-1970s, a centre for the development of the tools of biotechnology and molecular cloning. He joined others in applying those tools to RAS, and was among the pioneers is isolating the gene for renin itself, along with the prorenin and kallikrein genes, and the cardiac myosin heavy chain gene. [3] [5]

He and his team were among first to elucidate the biosynthetic pathway of renin, as well as key molecular mechanisms in renin's transcriptional and posttranscriptional control. [3] Taking that work further, he helped pioneer the field of genetic variation in hypertension. [3]

Morris has been active in the public debate around circumcision. [2] He has described pro-vaccine medical organisations, such as the Royal Australasian College of Surgeons, who are not in favour of routine non-therapeutic circumcision, as like anti-vaccine advocates. [6] [7] He has, however, also remarked that parents should "weigh up all of the pros and cons for themselves and make their own best decision". [8]

In the 2000s, he began to study the genetics of longevity, including the roles of FOXO3 and the sirtuins. [4] :154–155

Awards and honours

He was awarded the Royal Society of New South Wales' Edgeworth David Medal in 1985 [9] and in 1993 the University of Sydney awarded him a DSc. In 2003 he was elected as an Honorary Fellow of the American Heart Association Council for High Blood Pressure Research. In 2010 he gave the Lewis K. Dahl Memorial lecture, an award sponsored by the Council for High Blood Pressure Research in association with the American Heart Association. In 2014 the AHA awarded him the Irvine Page—Alva Bradley Lifetime Achievement Award. He was made a Member of the Order of Australia in the Queens Birthday Honours Awards in 2018. [2] [3] [10]

Related Research Articles

<span class="mw-page-title-main">Renin</span> Aspartic protease protein and enzyme

Renin, also known as an angiotensinogenase, is an aspartic protease protein and enzyme secreted by the kidneys that participates in the body's renin–angiotensin–aldosterone system (RAAS)—also known as the renin–angiotensin–aldosterone axis—that increases the volume of extracellular fluid and causes arterial vasoconstriction. Thus, it increases the body's mean arterial blood pressure.

<span class="mw-page-title-main">Renin–angiotensin system</span> Hormone system

The renin–angiotensin system (RAS), or renin–angiotensin–aldosterone system (RAAS), is a hormone system that regulates blood pressure, fluid and electrolyte balance, and systemic vascular resistance.

<span class="mw-page-title-main">Angiotensin-converting enzyme</span> Mammalian protein found in humans

Angiotensin-converting enzyme, or ACE, is a central component of the renin–angiotensin system (RAS), which controls blood pressure by regulating the volume of fluids in the body. It converts the hormone angiotensin I to the active vasoconstrictor angiotensin II. Therefore, ACE indirectly increases blood pressure by causing blood vessels to constrict. ACE inhibitors are widely used as pharmaceutical drugs for treatment of cardiovascular diseases.

Essential hypertension is the form of hypertension that by definition has no identifiable secondary cause. It is the most common type affecting 85% of those with high blood pressure. The remaining 15% is accounted for by various causes of secondary hypertension. Primary hypertension tends to be familial and is likely to be the consequence of an interaction between environmental and genetic factors. Prevalence of essential hypertension increases with age, and individuals with relatively high blood pressure at younger ages are at increased risk for the subsequent development of hypertension. Hypertension can increase the risk of cerebral, cardiac, and renal events.

<span class="mw-page-title-main">John Shine</span> Australian biochemist and molecular biologist

John Shine is an Australian biochemist and molecular biologist. Shine and Lynn Dalgarno discovered a nucleotide sequence, called the Shine-Dalgarno sequence, necessary for the initiation of protein synthesis. He directed the Garvan Institute of Medical Research in Sydney from 1990 to 2011. From 2018 to 2022, Shine was President of the Australian Academy of Science.

Jacques Genest was a Canadian physician and scientist. He founded the Institut de recherches cliniques de Montréal (IRCM) and was an emeritus professor at Université de Montréal and a professor at McGill University. Genest was best known for founding and leading several organizations related to clinical research in Québec and for his work on arterial hypertension.

<span class="mw-page-title-main">Pathophysiology of hypertension</span>

Pathophysiology is a study which explains the function of the body as it relates to diseases and conditions. The pathophysiology of hypertension is an area which attempts to explain mechanistically the causes of hypertension, which is a chronic disease characterized by elevation of blood pressure. Hypertension can be classified by cause as either essential or secondary. About 90–95% of hypertension is essential hypertension. Some authorities define essential hypertension as that which has no known explanation, while others define its cause as being due to overconsumption of sodium and underconsumption of potassium. Secondary hypertension indicates that the hypertension is a result of a specific underlying condition with a well-known mechanism, such as chronic kidney disease, narrowing of the aorta or kidney arteries, or endocrine disorders such as excess aldosterone, cortisol, or catecholamines. Persistent hypertension is a major risk factor for hypertensive heart disease, coronary artery disease, stroke, aortic aneurysm, peripheral artery disease, and chronic kidney disease.

<span class="mw-page-title-main">Alberto Carlos Taquini</span> Argentine cardiologist (1905–1998)

Alberto Carlos Taquini was an Argentine cardiologist, clinical researcher and academic.

Dr. Manuel Martínez Maldonado, MD; MACP, an internist and nephrologist, administrator, educator, poet and author, has authored numerous scientific publications and edited several books. His research interests are the regulation of body fluids and the pathophysiology of blood pressure and its effects on the kidneys. He also focuses on the renin angiotensin system, a hormone system that helps regulate long-term blood pressure and blood volume in the body and which is controlled primarily by the kidneys. His clinical research has included polycycstic kidney disease, renal stones and hypercalcemia. Martinez-Maldonado has occupied numerous positions, including Vice President for Research at Oregon Health and Sciences University (1998-2000), President and Dean of the Ponce School of Medicine (2000–2006). He was the executive vice president for research at the University of Louisville from 2000 to 2009.

Madhav Gajanan Deo is an Indian oncologist, pathologist and educationist, known for his contributions to the field of Molecular medicine. He is the founder president of the Indian Association of Cancer Research and one of the founders of the Moving Academy of Medicine and Biomedicine. He is a recipient of the Om Prakash Bhasin Award. The Government of India awarded him the fourth highest civilian award of Padma Shri in 1990.

Rhian M. Touyz Koppel MBBCh, MSc (Med), PhD, FRCP, FRSE, FMedSci, FCAHS is a Canadian medical researcher. She is currently serving as the Executive Director and Chief Scientific Officer of the Research Institute of the McGill University Health Centre in Montreal, Canada, since 2021. A clinician scientist, her research primarily focuses on hypertension and cardiovascular disease.

Judith Ann Whitworth is an Australian medical researcher in the areas of kidney function and blood pressure. Now an emeritus professor, she is the former director of the John Curtin School of Medical Research and Howard Florey Professor of Medical Research at the Australian National University (ANU).

<span class="mw-page-title-main">Harriet P. Dustan</span> American physician

Harriet Pearson Dustan (1920–1999) was an American physician who is known for her pioneering contributions to effective detection and treatment of hypertension. She was the first woman to serve on the Board of Governors of the American Board of Internal Medicine.

Eugenie Ruth Lumbers is an Australian medical researcher whose work has focused on the role of the renin-angiotensin system in fetal development and in women's health.

John Douglas Swales (1935–2000) was an English cardiologist, professor of medicine, medical journal editor, and internationally recognised expert on hypertension.

<span class="mw-page-title-main">Pierre Corvol</span> French doctor and biology researcher

Pierre Corvol is a French doctor and biology researcher. He was director of the Collège de France from 2006 to August 2012.

Harry Goldblatt was a pathologist who is known for his discovery of the role of the kidneys in the regulation of blood pressure.

Prorenin is a protein that constitutes a precursor for renin, the hormone that activates the renin–angiotensin system, which serves to raise blood pressure. Prorenin is converted into renin by the juxtaglomerular cells, which are specialised smooth muscle cells present mainly in the afferent, but also the efferent, arterioles of the glomerular capillary bed.

John Philip Chalmers is an Australian medical researcher, best known for his work in the field of cardiovascular physiology, specifically for his research into hypertension.

References

  1. "Morris, Brian J. (Brian James), 1950-". Library of Congress. Retrieved 23 August 2018.
  2. 1 2 3 "Professor Emeritus Brian Morris". University of Sydney. Retrieved 22 August 2018.
  3. 1 2 3 4 5 Morris, B. J. (10 January 2011). "2010 Dahl Lecture: Renin, Genes, and Beyond: 40 Years of Molecular Discoveries in the Hypertension Field". Hypertension. 57 (3): 538–548. doi: 10.1161/HYPERTENSIONAHA.110.166967 . PMID   21220705. Open Access logo PLoS transparent.svg
  4. 1 2 Triennial Report 2013-2015 (PDF). Bosch Institute of Medical Research at University of Sydney. 3 November 2016. Archived from the original (PDF) on 23 August 2018.
  5. Metherell, Mark (31 October 2011). "Thriving under pressure: scientist unlocks mysteries of hypertension". The Sydney Morning Herald. Retrieved 6 February 2015.
  6. Collier, R. (28 November 2011). "Ugly, messy and nasty debate surrounds circumcision". Canadian Medical Association Journal. 184 (1): E25–E26. doi:10.1503/cmaj.109-4017. PMC   3255195 . PMID   22125336.
  7. Zadrozny, Brandy (2 April 2014). "New Study Says Benefits of Circumcision Outweigh Risks 100 to 1". The Daily Beast. Retrieved 31 March 2015.
  8. "MEDICAL BENEFITS FROM CIRCUMCISION". 14 October 2002. Archived from the original on 14 October 2002. Retrieved 19 June 2020.
  9. "The Edgeworth David Medal". The Royal Society of NSW. Retrieved 22 June 2020.
  10. "2018 Queen's Birthday Honours List" (PDF). Archived (PDF) from the original on 27 February 2020.